blex 404
Small moleculeexperimental
Clinical trial activity
4 trials · 3 clinical orgs · 0 marketing orgs
Phase 1
3
Phase 2
4
Phase 3
0
Phase 4
0
Earliest trial started Aug 1, 2016 (NCT02802423)
Timeline
Indications
Mechanism of action
- UnclearUnclear
Unclear unclear
Chemistry & pharmacology
Oral
No
Parenteral
No
Topical
No
Also known as
- blex 404
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT05764928 | Phase 1/Phase 2 (Phase 2) | Jul 1, 2024 | Rgene Corporation |
| NCT03301805 | Phase 1/Phase 2 (Phase 2) | Jun 1, 2018 | Rgene Corporation |
| NCT02944955 | Phase 2 | Feb 1, 2017 | BioLite, Inc. |
| NCT02802423 | Phase 1/Phase 2 (Phase 2) | Aug 1, 2016 | BioLite, Inc., Government of Taiwan |
Showing 4 of 4 trials
Page 1 / 1
Organizations
Research & Development (3)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| BioLite, Inc. | For profit | 2 | 2 | 1 | 2016 |
| Rgene Corporation | For profit | 2 | 2 | 1 | 2018 |
| Government of Taiwan | Government | 1 | 0 | 1 | 2016 |
3 organizations
Page 1 / 1